Cardiff Lexington Corporation (CDIX)
OTCMKTS · Delayed Price · Currency is USD
1.500
-0.180 (-10.71%)
At close: Oct 24, 2025
Cardiff Lexington Revenue
Cardiff Lexington had revenue of $2.79M in the quarter ending June 30, 2025, with 89.52% growth. This brings the company's revenue in the last twelve months to $10.18M, up 6.32% year-over-year. In the year 2024, Cardiff Lexington had annual revenue of $8.27M, down -30.23%.
Revenue (ttm)
10.18M
Revenue Growth
+6.32%
P/S Ratio
2.93
Revenue / Employee
636.31K
Employees
17
Market Cap
29.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.27M | -3.58M | -30.23% |
| Dec 31, 2023 | 11.85M | 1.16M | 10.85% |
| Dec 31, 2022 | 10.69M | 814.14K | 8.24% |
| Dec 31, 2021 | 9.88M | 6.43M | 186.10% |
| Dec 31, 2020 | 3.45M | -254.30K | -6.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Cardiff Lexington News
- 2 months ago - Cardiff Lexington Announces Second Quarter 2025 Financial Results - Accesswire
- 2 months ago - Cardiff Lexington To Report Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 26, 2025 - Accesswire
- 2 months ago - Cardiff Lexington Postpones Second Quarter 2025 Earnings Press Release and Investor Call - Accesswire
- 3 months ago - Cardiff Lexington Announces Second Quarter 2025 Financial Results - Accesswire
- 5 months ago - Cardiff Lexington Announces Uplisting to OTCQB Venture Market - Accesswire
- 5 months ago - Cardiff Lexington Announces First Quarter 2025 Financial Results - Accesswire
- 7 months ago - Cardiff Lexington Announces Fourth Quarter and Full Year 2024 Financial Results - Accesswire
- 1 year ago - Cardiff Lexington Announces Third Quarter 2024 Financial Results - Accesswire